ReviR Therapeutics
Developer of RNA therapeutics intended to treat cancer, rare genetic disorders, and infectious diseases. The company develops an artificial intelligence-based and computation-empowered platform to dis...
Valuation
$0
Share Price
N/A
Total Raised
$50M
Last Round
N/A